Breast cancer is one of the most common forms of cancer worldwide and a serious health concern as it is major type of cancer found in women. As a result, healthcare providers focus on its early detection in order to reduce the morbidity and mortality rates and increase survival chances. Mammography and ultrasound are well-established as the technologies for screening and early detection of breast cancer. Breast ultrasound system when used in mammography have presented promising results in detection of tumor in women with dense breasts. However, both the techniques, mammography and conventional breast ultrasound had some technical constrains, thereby paving a way for development of ABUS.
Automated breast ultrasound (ABUS) system is a recent technological development in the field of ultrasound imaging that was developed to obtain an operator independent system. ABUS is reproducible and obtains high resolution three dimensional imaging. ABUS is attributed with handling comfort, accuracy and time-efficiency. Various research and studies have proved ABUS possessing capabilities of higher sensitivity, cancer detection rate, diagnostic accuracy rates and image quality. Recent advancements in ABUS systems with the help of high-frequency transducers facilitated for a reproduction of superior quality images within short time.
COVID – 19 scenario analysis:
- The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
- Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
- Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
- Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
- Some research from China, has also stated that cancer patients are at higher risk as they’re vulnerable against SARS-CoV-2 and have higher chances of getting infected with the virus
- Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to automated breasts ultrasound has been reduced and this segment have to face negligence subsequently causing negative impact on automated breasts ultrasound systems market
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Increasing breast cancer prevalence and incidences, rising radiology market with growing awareness of patients toward the connection of breast density with breast cancer is fueling the demand for automated breast ultrasound system. Further, technological improvements in the development for upgraded imaging techniques along with increasing government support towards spreading the breast cancer awareness should further enhance industry demand. Furthermore, heavy investments and extensive research and the benefits of the automated breast ultrasound system such as 3D imaging, high quality imaging, coronal view, rapid results with assurance of improved diagnostic results are fueling the automated breasts ultrasound systems market growth. With rising cases of breast cancer every year, especially in the female population and rising healthcare expenditures would surge the growth for automated breast ultrasound systems (ABUS) market over the upcoming years. Around 58,000 new cases of breast cancer are detected in Germany annually, and the number is expected to increase by 20% over past 25 years. Obesity, reduced childbearing, hormone replacement therapy and age-related risks are the major reasons leading to growth in breast cancer cases; thus, creating high demand for automated breast ultrasound systems in the automated breasts ultrasound systems market.
However, the high cost and maintenance related to automated breast ultrasound systems would restrain the market growth. Furthermore, dearth of qualified and skilled specialists and professionals for operating the tools related to ABUS would hamper this market’s growth.
Rising number of breast cancer patients to drive the market
Breast cancer is the fifth leading cause of cancer deaths among women. At least 1 in 4 women diagnosed with cancer, has breast cancer, and such an alarming rise has triggered the need for effective treatment. Continuously increasing prevalence of the breast cancer across the globe have surged the demand for the automated breast ultrasound systems. The increasing numbers of genetic diseases in women along with increasing healthcare spending and governmental policies support fosters the automated breast ultrasound systems market growth. According to American Cancer Society, around 1.7 million new cancer cases are predicted to be diagnosed by 2018 and approximately over 600,000 Americans are expecting fatality due to cancer in 2018. Increasing expenditure in R&D activities has boosted the growth of automated breast ultrasound systems market. Cancer Research UK has spent USD 518 million on cancer research across the country to accelerate cancer surviving rate by 75% by 2034. The organization aims to increase up to 2.6% of GDP spending on cancer research by 2023. Further, higher per capita income of the people, favorable reimbursement policies, and increasing awareness about availability of diagnostic systems have fueled the growth of automated breast ultrasound systems market.
Technological advancements proving beneficial for the market
Advances in breast imaging technology and launch of innovative devices is aiding healthcare professionals and cancer patients diagnose breast cancer at an early stage and more effectively. Technological advancements is the key factor in the development of automated breast ultrasound system market. Key industry players are emphasizing on R&D activities related to several complementary technologies to improvise and enhance cancer screening in patients with dense breast, thus improving the efficiency of breast cancer detection. Developments in ABUS systems aim to reduce the side effects of conventional systems of breast imaging. For instance, GE Healthcare announced launch of Invenia ABUS 2.0 in the U.S. market. This system is attributed with more accurate cancer detection especially in women with dense breast.
In November 2016, QView Medical Company’s U.S. FDA approval for QVCAD was accepted. QVCAD is based on deep-learning algorithms and is the pioneer in computer-aided detection for ABUS.
Such technological advancements will increase the benefits and thus increasing the demand for ABUS systems augmenting the industry growth.
Key benefits of the report:
- This study presents the analytical depiction of the global automated breast ultrasound systems industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global automated breasts ultrasound systems market share.
- The current market is quantitatively analyzed to highlight the global automated breast ultrasound systems market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the automated breasts ultrasound systems market.
- The report provides a detailed global automated breasts ultrasound systems market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the automated breast ultrasound systems Market research report:
- Who are the leading market players active in the automated breast ultrasound systems market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the automated breasts ultrasound systems market?
- What are the projections for the future that will help in taking further strategic steps?
Automated Breasts Ultrasound Systems Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Applications |
|
 By End User |
|
 By Region |
|
 Key Market Players | GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V., SuperSonic Imagine., QView Medical Inc., Canon Medical Systems, Siemens AG, Nova Medical Imaging Technology Co. Ltd, SonoCine Inc., Metritrack Inc. |
Loading Table Of Content...
